156 related articles for article (PubMed ID: 17235114)
1. Management of a patient with a null low-density lipoprotein receptor mutation: a case report.
Kolovou GD; Dedoussis GV; Anagnostopoulou KK; Hatzigeorgiou GCh; Salpea KD; Choumerianou DM; Rammos S; Mikhailidis DP; Cokkinos DV
Angiology; 2006 Dec-2007 Jan; 57(6):729-32. PubMed ID: 17235114
[TBL] [Abstract][Full Text] [Related]
2. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
3. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
5. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
[TBL] [Abstract][Full Text] [Related]
6. Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
Pullinger CR; Kane JP; Malloy MJ
Expert Rev Cardiovasc Ther; 2003 May; 1(1):107-19. PubMed ID: 15030301
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM
Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793
[TBL] [Abstract][Full Text] [Related]
8. Homozygous hypercholesterolaemia and ezetimibe: a case report.
Hendriksz CJ; Norbury G; Tabrah S; Taylor A; Humphries SE
Acta Paediatr; 2004 Feb; 93(2):280-2. PubMed ID: 15046291
[TBL] [Abstract][Full Text] [Related]
9. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
Sampalis JS; Bissonnette S; Habib R; Boukas S;
Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
[TBL] [Abstract][Full Text] [Related]
10. Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.
Lahoz C; Peña R; Mostaza JM; Laguna F; García-Iglesias MF; Taboada M; Pintó X
Metabolism; 2005 Jun; 54(6):741-7. PubMed ID: 15931608
[TBL] [Abstract][Full Text] [Related]
11. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
[TBL] [Abstract][Full Text] [Related]
12. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
Lal SM; Katyal A
Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
[TBL] [Abstract][Full Text] [Related]
13. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C
Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459
[TBL] [Abstract][Full Text] [Related]
14. New mutant rabbit strain with hypercholesterolemia and atherosclerotic lesions produced by serial inbreeding.
Kurosawa T; Kusanagi M; Yamasaki Y; Senga Y; Yamamoto T
Lab Anim Sci; 1995 Aug; 45(4):385-92. PubMed ID: 7474877
[TBL] [Abstract][Full Text] [Related]
15. [Reducing low density lipoprotein-cholesterol levels by apheresis].
Reiber I; Gógl A
Orv Hetil; 1994 Mar; 135(11):563-8. PubMed ID: 8159408
[TBL] [Abstract][Full Text] [Related]
16. [Three-year-old boy--a homozygote for familiar hypercholesterolemia].
Dumić M; Uroic AS; Francetić I; Puretić Z; Matisić D; Kes P; Mikecin M; Reiner Z
Lijec Vjesn; 2007 May; 129(5):130-3. PubMed ID: 17695192
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.
Vuorio AF; Kovanen PT; Gylling H
Expert Rev Cardiovasc Ther; 2004 May; 2(3):405-15. PubMed ID: 15151486
[TBL] [Abstract][Full Text] [Related]
18. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
[TBL] [Abstract][Full Text] [Related]
20. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
